Fifteen percent of the MPN patient cohort (n = 61) displayed significant amounts of this short isoform detected by fragment analysis, which represented 4–34% of total JAK2 transcripts [105]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.